Medication info
Acrovin Tablet 200 mg (Acyclovir)

Acrovin Tablet 200 mg (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
SK Chemicals Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 198901700 · Notified 1989.09.05 · Insurance code 644701100

Summary

Main use
Treats and prevents herpes simplex (such as genital herpes), treats shingles, and treats chickenpox
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Take 200 mg of acyclovir per dose, 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, treatment should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Take 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be taken 2 times daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose, 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Take 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Take 800 mg of this medicine per dose, 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or impaired gastrointestinal absorption. 3) It is best to start treatment as soon as possible after infection; the sooner treatment is started, the better the effect. ○ Patients with renal impairment Use caution in patients with renal impairment, as they are more likely to experience neuropsychiatric adverse reactions; extend the dosing interval or reduce the dose as appropriate. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, for patients with severe renal impairment (creatinine clearance below 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance below 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 2 times daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 3 times daily at approximately 8-hour intervals.
Children's dosage
1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function Age 2 years and older: Same as for adults. Under 2 years: Administer 1/2 the adult dose. 2. Treatment of chickenpox in children aged 2 years and older Children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose), 4 times daily for 5 days.

Ingredients

Manufacturer
SK Chemicals Co., Ltd.

Efficacy & effects

Treats and prevents herpes simplex (such as genital herpes), treats shingles, and treats chickenpox

  • Genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • varicella-zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections of the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating varicella-zoster virus infections, particularly in alleviating pain that occurs during the acute phase. However, its effectiveness for postherpetic neuralgia has not yet been definitively proven. This medication is also used for the treatment of chickenpox in children aged 2 years and older. Overall, it is a useful medication for the treatment and prevention of viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Take 200 mg of acyclovir per dose, 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, treatment should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Take 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be taken 2 times daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose, 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Take 200 mg of this medicine per dose, 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Take 800 mg of this medicine per dose, 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or impaired gastrointestinal absorption. 3) It is best to start treatment as soon as possible after infection; the sooner treatment is started, the better the effect. ○ Patients with renal impairment Use caution in patients with renal impairment, as they are more likely to experience neuropsychiatric adverse reactions; extend the dosing interval or reduce the dose as appropriate. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, for patients with severe renal impairment (creatinine clearance below 10 mL per minute), it is preferable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance below 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 2 times daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 3 times daily at approximately 8-hour intervals.

Children's dosage

1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function Age 2 years and older: Same as for adults. Under 2 years: Administer 1/2 the adult dose. 2. Treatment of chickenpox in children aged 2 years and older Children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose), 4 times daily for 5 days.

Precautions

This medication should not be used in patients who are allergic to it or its ingredients, or who have had hypersensitivity reactions to similar drugs. Caution is required when used in patients with impaired kidney function as there may be a risk of neuropsychiatric effects. Patients with poor liver function should be administered with caution as their liver function may worsen. It should be used in infants and children only when absolutely necessary, and especially in newborns or low-birth-weight infants, caution is required as its safety has not been established. Elderly patients, who often have impaired kidney function, should be used cautiously while adjusting the dose and dosing interval as the medication may stay in the body longer and the possibility of adverse reactions increases. If symptoms such as allergic reactions or skin rashes, fever, blisters, urticaria occur while taking this medication, usage should be discontinued immediately and medical attention sought. Rarely, symptoms such as shock, consciousness disturbance, seizures, or psychiatric symptoms may appear, in which case medical personnel should be notified immediately. This medication can burden the kidneys, so it is important to ensure adequate fluid intake during the treatment period to prevent dehydration and reduce renal toxicity. Particular attention should be paid to kidney function when administering at high doses. This medication may interact with specific drugs, so if other medications are being taken, it is essential to inform a doctor or pharmacist. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, and breastfeeding women should discontinue nursing. Caution should be exercised when driving or operating hazardous machinery during treatment as consciousness disturbance may occur. In the case of overdose, serious neurological effects or renal failure may occur, so the dosage should be strictly adhered to and if abnormal symptoms appear, immediate medical attention should be sought.

Side effects

  • anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticarial rash
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • derealization
  • agitation
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • excitement
  • amnesia
  • insomnia
  • anxiety
  • talking to oneself
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • agitation
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • excitement
  • epileptic seizures
  • state of coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air and moisture, and preferably in a cool, dry place below 25 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.